4.7 Review

Recent progress in tumor photodynamic immunotherapy

期刊

CHINESE CHEMICAL LETTERS
卷 31, 期 7, 页码 1709-1716

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cclet.2020.02.007

关键词

Cancer therapy; Photodynamic therapy; Immunotherapy; Reactive oxygen species; Singlet oxygen

资金

  1. National Natural Science Foundation of China (NSFC) [81773667]
  2. NSFC Projects of International Cooperation and Exchanges [81811540416]
  3. China Pharmaceutical University [2242019K3DNZ2]
  4. Southeast University [2242019K3DNZ2]
  5. Nanjing Medical University [2242019K3DNZ2]

向作者/读者索取更多资源

Photodynamic therapy (PDT) is a promising alternative approach for effective cancer treatment, which can directly destroy local tumor cells due to the generation of cytotoxic singlet oxygen and reactive oxygen species (ROS) in the tumor cells. Intriguingly, PDT-mediated cell death is also associated with anti-tumor immune response. However, immunosuppression of tumor microenvironment is able to limit the immune response induced by PDT, it is therefore necessary to combine with immunocheckpoint inhibitor and immunoadjuvant for synergistic treatment of tumors. Herein, the recent advances of PDT, immunotherapy, and photodynamic immunotherapy are reviewed (C) 2020 Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据